Average Co-Inventor Count = 3.99
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (27 from 3,223 patents)
2. Cellerant Therapeutics, Inc. (5 from 17 patents)
3. Genetech, Inc. (3 from 98 patents)
4. Cantargia Ab (1 from 18 patents)
5. Genenech, Inc. (1 from 1 patent)
37 patents:
1. 11873330 - Cysteine engineered antibodies and conjugates
2. 11866496 - Humanized anti-CD79B antibodies and immunoconjugates and methods of use
3. 11359025 - Anti-IL1-RAP antibodies
4. 11072662 - Humanized anti-CLL-1 antibodies
5. RE48558 - Anti-CD79B antibodies and immunoconjugates and methods of use
6. 10981987 - Humanized anti-CD79b antibodies and immunoconjugates and methods of use
7. 10898580 - Isoquinolidinobenzodiazepines
8. 10604557 - Cysteine engineered antibodies and conjugates
9. 10556966 - Anti-HER2 antibodies and immunoconjugates
10. 10544218 - Anti-CD79B antibodies and immunoconjugates and methods of use
11. 10494432 - Anti-CD79B antibodies and immunoconjugates and methods of use
12. 10350218 - Isoquinolidinobenzodiazepine (IQB)-1(chloromethyl)-2,3-dihydro-1H-benzo[e]indole (CBI) dimers
13. 10314846 - Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepines
14. 10179820 - Anti-HER2 antibodies and immunoconjugates
15. RE47194 - Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates